Behavioral Program for Weight Loss
Trial Summary
Will I have to stop taking my current medications?
The trial requires that you stop taking medications that significantly affect appetite, such as weight loss medications, atypical antipsychotics, and stimulants, as well as chronic use of anticoagulants.
What data supports the effectiveness of the treatment Behavioral Weight Loss Program?
Research shows that behavioral treatments can lead to a 10% weight loss, which improves health, and a comprehensive program can maintain 83% of initial weight loss after 18 months. Additionally, multistep cognitive behavioral therapy has resulted in a 15% weight loss over 12 months, with promising long-term results.12345
Is the Behavioral Program for Weight Loss safe for humans?
How is the Behavioral Weight Loss Program treatment different from other treatments for obesity?
The Behavioral Weight Loss Program is unique because it focuses on changing behaviors related to eating, exercise, and attitudes, rather than just diet or exercise alone. It involves a comprehensive approach that includes mental conditioning and social support, which helps maintain weight loss over time.1561011
What is the purpose of this trial?
Behavioral weight loss programs for obesity can result in weight loss and health benefits. However, behavioral weight loss often stops despite efforts to continue losing weight, this can be called an involuntarily weight loss plateau. This study investigates changes in metabolism and/or the brain that contribute to the occurrence of an involuntary weight loss plateau.
Research Team
Marian L. Neuhouser
Principal Investigator
Fred Hutch Cancer Center
Ellen Schur, MD, MS
Principal Investigator
University of Washington
Jenny Tong, MD
Principal Investigator
University of Washington/VA Puget Sound
Eligibility Criteria
This trial is for individuals who are experiencing obesity and want to lose weight. Participants should be willing to follow a Behavioral Weight Loss Program but have hit an involuntary weight loss plateau despite their efforts.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Initial Study Visits
Participants complete 3 in-person study visits for baseline assessments including questionnaires, blood draws, brain MRIs, body measurements, DXA scans, breathing tests, and biopsies.
Weight Loss Program
Participants undergo a 6-month behavioral weight loss program delivered remotely.
Additional Study Visits
Some participants may be invited to complete 3 additional in-person visits for further assessments.
Follow-up
Participants are monitored for physiological changes and weight loss plateau occurrence.
Treatment Details
Interventions
- Behavioral Weight Loss Program
Behavioral Weight Loss Program is already approved in United States, European Union for the following indications:
- Obesity
- Weight Loss
- Type 2 Diabetes Prevention
- Obesity
- Weight Loss
- Type 2 Diabetes Prevention
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Washington
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator